Background: Sodium bicarbonate (NaHCO) is a well-established nutritional ergogenic aid, though gastrointestinal (GI) distress is a common side-effect. Delayed-release NaHCO may alleviate GI symptoms and enhance bicarbonate bioavailability following oral ingestion, although this has yet to be confirmed.
Methods: In a randomised crossover design, pharmacokinetic responses and acid-base status were compared following two forms of NaHCO, as were GI symptoms.
Background: Individual time to peak blood bicarbonate (HCO) has demonstrated good to excellent reproducibility following ingestion of both 0.2 g kg body mass (BM) and 0.3 g kg BM sodium bicarbonate (NaHCO), but the consistency of the time trial (TT) performance response using such an individualised NaHCO ingestion strategy remains unknown.
View Article and Find Full Text PDF